sulfinpyrazone has been researched along with Brain Vascular Disorders in 80 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These trials were prompted by earlier observations that aspirin takers seemed to fare better after acute myocardial infarction and were further stimulated by the recent growth of knowledge about the role of vascular and platelet prostaglandins." | 5.05 | Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials. ( Castaldi, PA, 1981) |
| "Sulfinpyrazone1 has long been recognised as a potent uricosuric agent, but has more recently been studied extensively as a platelet inhibitor and antithrombotic agent." | 3.75 | Sulfinpyrazone: a review of its pharmacological properties and therapeutic use. ( Margulies, EH; Sherry, S; White, AM, 1980) |
| "Data from the Aspirin in Transient Ischemic Attack (AITIA) study, an ongoing study of two platelet antiaggregant drugs, and other published therapeutic trials were reviewed to determine whether the severity of stroke is reduced in patients taking platelet antiaggregants." | 3.75 | Does platelet antiaggregant therapy lessen the severity of stroke? ( Fields, WS; Gary, H; Grotta, JC; Lemak, NA; Vital, D, 1985) |
| "Ticlopidine was more effective than aspirin in reducing stroke in both males and females." | 2.38 | Antiplatelet therapy in the prevention of stroke. ( Easton, JD, 1991) |
| " Starting dosage was 200 mg per day; daily dosage was then increased every 4 days of 200 mg, or kept constant for another 4 days, according to each patient's renal function, up to 800 mg per day." | 1.27 | [Renal tolerance of an incremental dosage regimen of anturan in the aged with altered renal function]]. ( Bertolini, G; Borghi, C; Naliato, P, 1985) |
| "In patients with mitral valve prolapse, TE appears to occur very infrequently." | 1.26 | Platelet survival time and thromboembolism in patients with mitral valve prolapse. ( Rainwater, J; Steele, P; Vogel, R; Weily, H, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 76 (95.00) | 18.7374 |
| 1990's | 4 (5.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritter, JM | 1 |
| Genton, E | 4 |
| Kelton, JG | 1 |
| Agostoni, A | 1 |
| Tullio, D | 1 |
| Buckler, P | 1 |
| Douglas, AS | 2 |
| Webster, J | 1 |
| Sherry, S | 2 |
| Guiraud-Chaumeil, B | 1 |
| Wilkerson, RJ | 1 |
| Liem, PH | 1 |
| Carter, WJ | 1 |
| Bousser, MG | 1 |
| Lechner, H | 1 |
| Ott, E | 1 |
| Bertha, G | 1 |
| Eichner, ER | 1 |
| Barnett, HJ | 5 |
| Taylor, DW | 3 |
| Gent, M | 7 |
| Sackett, DL | 3 |
| Bouchier-Hayes, D | 1 |
| Pagano, T | 1 |
| Nair, CK | 1 |
| Sketch, MH | 1 |
| Polli, EE | 1 |
| Cortellaro, M | 1 |
| Held, K | 1 |
| Fontanilles, F | 1 |
| Poliwoda, H | 1 |
| Whisnant, JP | 1 |
| Birgens, HS | 1 |
| Hansen, MS | 1 |
| Margulies, EH | 1 |
| White, AM | 1 |
| Hirsh, J | 5 |
| Fuster, V | 4 |
| Chesebro, JH | 1 |
| Cristol, R | 1 |
| Turpie, AG | 2 |
| Warlow, CP | 1 |
| Castaldi, PA | 1 |
| Meloche, JP | 1 |
| Byer, JA | 1 |
| Easton, JD | 2 |
| Rubegni, M | 1 |
| Provvedi, D | 1 |
| Bellini, PG | 1 |
| Bandinelli, C | 1 |
| De Mauro, G | 1 |
| Didisheim, P | 3 |
| Weiss, HJ | 1 |
| Dettori, AG | 1 |
| Pini, M | 1 |
| Quintavalla, R | 1 |
| Mitchell, JR | 1 |
| Ostendorf, P | 1 |
| Gantmacher, ML | 1 |
| Steele, P | 2 |
| Weily, H | 1 |
| Rainwater, J | 1 |
| Vogel, R | 1 |
| Armitage, P | 1 |
| Blakely, JA | 1 |
| Harker, LA | 4 |
| Corn, M | 1 |
| Gotshall, RA | 1 |
| Robertson, JT | 1 |
| Dugdale, M | 1 |
| Salky, N | 1 |
| Robinson, H | 1 |
| Kalendovsky, Z | 1 |
| Austin, J | 1 |
| Ferlito, S | 1 |
| Stachenko, SJ | 1 |
| Bravo, G | 1 |
| Côté, R | 1 |
| Boucher, J | 1 |
| Battista, RN | 1 |
| Inzitari, D | 1 |
| Fratiglioni, L | 1 |
| Baldereschi, M | 1 |
| Candelise, L | 1 |
| Anzalone, N | 1 |
| Bonatti, ML | 1 |
| Prencipe, M | 1 |
| Gandolfo, C | 1 |
| Mamoli, A | 1 |
| Rasura, M | 1 |
| Makuch, R | 1 |
| Johnson, M | 1 |
| Sze, PC | 1 |
| Reitman, D | 1 |
| Pincus, MM | 1 |
| Sacks, HS | 1 |
| Chalmers, TC | 1 |
| Maekawa, T | 1 |
| Lecompte, T | 1 |
| Samama, M | 1 |
| David, JL | 1 |
| Grotta, JC | 1 |
| Lemak, NA | 1 |
| Gary, H | 1 |
| Fields, WS | 1 |
| Vital, D | 1 |
| Oelz, O | 1 |
| Bertolini, G | 1 |
| Naliato, P | 1 |
| Borghi, C | 1 |
| Kazmier, FJ | 1 |
| Millikan, CH | 1 |
33 reviews available for sulfinpyrazone and Brain Vascular Disorders
| Article | Year |
|---|---|
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Plate | 1983 |
[Role of antiaggregant platelet drugs in thromboembolism].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aspirin; Cerebrova | 1981 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Current therapy of cerebrovascular disease.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ische | 1984 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggrega | 1983 |
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosi | 1984 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Dise | 1980 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; | 1980 |
Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
Topics: Animals; Anti-Arrhythmia Agents; Antibody Formation; Aspirin; Blood Platelets; Cardiovascular Diseas | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
Cerebrovascular disease.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Platelets; Cerebrovascular Disorders; Fibrin | 1981 |
Actions and clinical status of platelet-suppressive agents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Dis | 1978 |
Platelet function inhibitors: their clinical use.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease | 1978 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
The pathophysiology of transient cerebral ischemic attacks.
Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc | 1979 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
Antiplatelet therapy in the prevention of stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomize | 1991 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery | 1991 |
Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; | 1991 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; | 1990 |
Issues in planning and interpreting active control equivalence studies.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Random Allocation; Rese | 1989 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
[Antiplatelet therapy of thrombosis].
Topics: Animals; Aspirin; Cerebrovascular Disorders; Coronary Disease; Humans; Postoperative Complications; | 1986 |
Does platelet antiaggregant therapy lessen the severity of stroke?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Humans; Ischemic | 1985 |
[Controversy on platelet-inhibiting drugs].
Topics: Angina, Unstable; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Cor | 1985 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Dis | 1971 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol | 1974 |
31 trials available for sulfinpyrazone and Brain Vascular Disorders
| Article | Year |
|---|---|
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascula | 1980 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
[Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dihydroergotoxine; Dipyri | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Prevention of stroke.
Topics: Aged; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Female; He | 1984 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Dise | 1980 |
The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Canada; Cerebrovascular Disorders; Clinical Trials a | 1980 |
Randomized trial of therapy with platelet antiaggregants for threatened stroke.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Com | 1980 |
Randomized trial of therapy with platelet antiaggregants for threatened stroke. 2: Observations on the pathogenesis and natural history of threatened stroke.
Topics: Adolescent; Adult; Aged; Carotid Artery Thrombosis; Carotid Artery, Internal; Cerebrovascular Disord | 1980 |
Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
Topics: Animals; Anti-Arrhythmia Agents; Antibody Formation; Aspirin; Blood Platelets; Cardiovascular Diseas | 1980 |
A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
Topics: Actuarial Analysis; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Death, Sud | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1981 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamo | 1981 |
Antiplatelet therapy and cerebrovascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Double- | 1982 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical T | 1978 |
A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; | 1978 |
Preventing stroke.
Topics: Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Female; H | 1978 |
The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Male; Research Design; | 1978 |
Aspirin to prevent a stroke?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Ischemic Attack, Trans | 1978 |
Does aspirin prevent stroke?
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyr | 1979 |
The role of platelets in transient ischemic attacks and cerebral vascular accidents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Transient; Mal | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes.
Topics: Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Ischemic Attack, Trans | 1975 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; | 1990 |
Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Human | 1988 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1986 |
Does platelet antiaggregant therapy lessen the severity of stroke?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Humans; Ischemic | 1985 |
[Controversy on platelet-inhibiting drugs].
Topics: Angina, Unstable; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Cor | 1985 |
26 other studies available for sulfinpyrazone and Brain Vascular Disorders
| Article | Year |
|---|---|
Placebo-controlled, double-blind clinical trials can impede medical progress.
Topics: Adrenergic beta-Antagonists; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Bl | 1980 |
[Current status of medical treatment].
Topics: Aminophylline; Animals; Anticoagulants; Aspirin; Barbiturates; Brain Ischemia; Cerebrovascular Disor | 1980 |
Antithrombotic treatment.
Topics: Ancrod; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Drug Administration Schedule; He | 1983 |
Antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dextrans; Dipyridamole; Epopr | 1983 |
The relationship between basic biomedical research and the design and analysis of clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Kinetics; Research Design; Sul | 1983 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovasc | 1983 |
Use of common antiplatelet drugs for vascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Couma | 1983 |
[Conservative therapy of stroke from an internist's viewpoint].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Digitalis Glycosides; Dipyridamole; Diuretics; H | 1983 |
[Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program].
Topics: Aged; Arteriovenous Shunt, Surgical; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Huma | 1980 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; | 1982 |
Therapy of ischemic cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Carotid Arteries; Cerebrovascular Disorders; Endarterectomy | 1980 |
Aspirin and stroke prevention.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Transient; Male; Risk; S | 1978 |
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Diso | 1975 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders | 1979 |
Platelet survival time and thromboembolism in patients with mitral valve prolapse.
Topics: Adult; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Chromium Radioisotopes; Female; Hu | 1979 |
The Canadian cooperative study of platelet suppressant therapy in threatened stroke.
Topics: Aspirin; Blood Platelets; Canada; Cerebrovascular Disorders; Double-Blind Method; Evaluation Studies | 1979 |
Trials of antiplatelet drugs: some methodological considerations.
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Drug Therapy, Combination; Fem | 1979 |
Platelet suppressing drugs in arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Humans; Myocardial | 1978 |
Stroke prevention.
Topics: Aspirin; Cerebrovascular Disorders; Drug Therapy, Combination; Humans; Sex Factors; Sulfinpyrazone | 1978 |
Anticoagulants and platelet-inhibiting drugs in stroke.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation; Sulf | 1977 |
Using antithrombotic therapy in ischemic cerebrovascular disease.
Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intra | 1977 |
Increased platelet aggregability in young patients with stroke. Diagnosis and therapy.
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cell Survival; Cerebrovascular Di | 1975 |
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinatio | 1988 |
[Mode of action and clinical evaluation of platelet aggregation inhibitors].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Graft Occlusion, Vascular; Humans; Ketanserin; Myo | 1987 |
[Renal tolerance of an incremental dosage regimen of anturan in the aged with altered renal function]].
Topics: Aged; Cerebrovascular Disorders; Coronary Disease; Creatinine; Dose-Response Relationship, Drug; Dru | 1985 |
Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Blood Pressure; Cardiac Output; Carotid Arteries; Cerebral Angiography; Cer | 1973 |